FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3075820966> ?p ?o ?g. }

• W3075820966 abstract "Abstract Objective Gonorrhea is the second most common sexually transmitted bacterial infection (STI) next to Chlamydia. Untreated cases could results in major complications like pelvic inflammatory disease (PID), ectopic pregnancy, infertility, miscarriage, fetal death and congenital infections. Gonorrhea has been treated with antibiotics for more than eight decades. However, the emergence and spread of antimicrobial resistance (AMR) in gonococcus seriously compromises the management of the disease. The aim of this review was to describe the current developments in the field of azithromycin resistant gonococci. Methods Literatures published in English in the last 10 years were retrieved from PubMed, SCOPUS, Google scholar, Cochrane library and the Google databases using relevant searching terms. Results Gonococcus is capable of using a number of strategies to confer resistance as the bacterium has an extraordinary capacity to alter its genome. So far the accumulated data on the field showed that the world is heading towards a pandemic of extensively drug-resistant (XDR) gonococcus which is now seems to be evolving into a true “superbug”. Hence, in the near future gonorrhea may become untreatable on the international basis unless new drugs become available. An antibiotic resistance in gonococcus has been noted beginning in 1940s against sulfonamides. Since then, resistance has rapidly emerged to penicillins, tetracyclines, macrolides, fluoroquinolones, and cephalosporins. Currently, in most nations, the injectable extended-spectrum cephalosporin (ESC), i.e. ceftriaxone based therapy is the only remaining option for gonorrhea. Based on the WHO and the US-CDC recommendations, countries are increasingly using a combination of cephalosporin and azithromycin for the treatment of gonorrhoea. Azithromycin revolutionized gonoccocal therapy as it shortened treatment time by more than half from 7 to 14 days and improved patient compliance due to high tissue levels and long half-life. However, constantly emerging reports from different parts of the globe showed that N. gonorrhoeae is developing significant level of resistance against azithromycin, and so far more than 33% level of resistance was reported. Two strategies have been commonly implicated in gonococcal resistance against azithromycin: over expression of an efflux pump (due to mutations at mtrR coding region) and decreased antimicrobial affinity (due to mutations in genes encoding the 23S ribosomal subunit). Conclusions With no alternative antimicrobial treatment options for gonorrhoea and only a few new drugs in the development pipeline, it is necessary to monitor drug resistance and optimize treatment regimens regularly. Moreover, investigations for novel drugs should be wired." @default.
• W3075820966 created "2020-08-24" @default.
• W3075820966 creator A5000292740 @default.
• W3075820966 creator A5038509310 @default.
• W3075820966 creator A5068658631 @default.
• W3075820966 creator A5086720180 @default.
• W3075820966 date "2020-08-18" @default.
• W3075820966 modified "2023-10-16" @default.
• W3075820966 title "Azithromycin resistant gonococci: a literature review" @default.
• W3075820966 cites W1790513468 @default.
• W3075820966 cites W1967593111 @default.
• W3075820966 cites W1987523762 @default.
• W3075820966 cites W1987952286 @default.
• W3075820966 cites W1995576316 @default.
• W3075820966 cites W2031703906 @default.
• W3075820966 cites W2032241110 @default.
• W3075820966 cites W2041170616 @default.
• W3075820966 cites W2050597595 @default.
• W3075820966 cites W2079541485 @default.
• W3075820966 cites W2092103784 @default.
• W3075820966 cites W2095530067 @default.
• W3075820966 cites W2097274712 @default.
• W3075820966 cites W2100819850 @default.
• W3075820966 cites W2142618138 @default.
• W3075820966 cites W2149389805 @default.
• W3075820966 cites W2166241233 @default.
• W3075820966 cites W2166557653 @default.
• W3075820966 cites W2203537645 @default.
• W3075820966 cites W2271003514 @default.
• W3075820966 cites W2333143227 @default.
• W3075820966 cites W2423153849 @default.
• W3075820966 cites W2463322101 @default.
• W3075820966 cites W2520519038 @default.
• W3075820966 cites W2520703081 @default.
• W3075820966 cites W2522566804 @default.
• W3075820966 cites W2599437121 @default.
• W3075820966 cites W2601265751 @default.
• W3075820966 cites W2611944727 @default.
• W3075820966 cites W2619561938 @default.
• W3075820966 cites W2725319213 @default.
• W3075820966 cites W2735841939 @default.
• W3075820966 cites W2755924901 @default.
• W3075820966 cites W2773100799 @default.
• W3075820966 cites W2785659830 @default.
• W3075820966 cites W2786408385 @default.
• W3075820966 cites W2789808681 @default.
• W3075820966 cites W2792230914 @default.
• W3075820966 cites W2943429827 @default.
• W3075820966 cites W322134550 @default.
• W3075820966 doi "https://doi.org/10.1186/s13756-020-00805-7" @default.
• W3075820966 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7436955" @default.
• W3075820966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32811545" @default.
• W3075820966 hasPublicationYear "2020" @default.
• W3075820966 type Work @default.
• W3075820966 sameAs 3075820966 @default.
• W3075820966 citedByCount "31" @default.
• W3075820966 countsByYear W30758209662020 @default.
• W3075820966 countsByYear W30758209662021 @default.
• W3075820966 countsByYear W30758209662022 @default.
• W3075820966 countsByYear W30758209662023 @default.
• W3075820966 crossrefType "journal-article" @default.
• W3075820966 hasAuthorship W3075820966A5000292740 @default.
• W3075820966 hasAuthorship W3075820966A5038509310 @default.
• W3075820966 hasAuthorship W3075820966A5068658631 @default.
• W3075820966 hasAuthorship W3075820966A5086720180 @default.
• W3075820966 hasBestOaLocation W30758209661 @default.
• W3075820966 hasConcept C114851261 @default.
• W3075820966 hasConcept C126322002 @default.
• W3075820966 hasConcept C177713679 @default.
• W3075820966 hasConcept C190139176 @default.
• W3075820966 hasConcept C203014093 @default.
• W3075820966 hasConcept C2776520383 @default.
• W3075820966 hasConcept C2778082588 @default.
• W3075820966 hasConcept C2778416477 @default.
• W3075820966 hasConcept C2778907293 @default.
• W3075820966 hasConcept C2779166590 @default.
• W3075820966 hasConcept C2779234561 @default.
• W3075820966 hasConcept C2779245376 @default.
• W3075820966 hasConcept C2780122209 @default.
• W3075820966 hasConcept C29456083 @default.
• W3075820966 hasConcept C2993569511 @default.
• W3075820966 hasConcept C3013748606 @default.
• W3075820966 hasConcept C501593827 @default.
• W3075820966 hasConcept C512399662 @default.
• W3075820966 hasConcept C54355233 @default.
• W3075820966 hasConcept C64778159 @default.
• W3075820966 hasConcept C71924100 @default.
• W3075820966 hasConcept C86803240 @default.
• W3075820966 hasConcept C89423630 @default.
• W3075820966 hasConcept C94665300 @default.
• W3075820966 hasConceptScore W3075820966C114851261 @default.
• W3075820966 hasConceptScore W3075820966C126322002 @default.
• W3075820966 hasConceptScore W3075820966C177713679 @default.
• W3075820966 hasConceptScore W3075820966C190139176 @default.
• W3075820966 hasConceptScore W3075820966C203014093 @default.
• W3075820966 hasConceptScore W3075820966C2776520383 @default.
• W3075820966 hasConceptScore W3075820966C2778082588 @default.
• W3075820966 hasConceptScore W3075820966C2778416477 @default.
• W3075820966 hasConceptScore W3075820966C2778907293 @default.
• W3075820966 hasConceptScore W3075820966C2779166590 @default.

• next